BRCA1 and ovarian cancer: Most common type of mutation observed among breast and ovarian cancer patients is deletion of multiple functional domains of BRCA1/2 that lead to not only impaired DNA repair but also abrogation of cell cycle checkpoints and transcriptional mis-regulation of genes, which eventually lead to global genomic instability.